Oncology Unscripted With John Marshall

Main Topic: In this episode of Oncology Unscripted, Dr John Marshall discusses major post-ASCO developments in GI oncology, including new RAS inhibitor data in pancreatic cancer and the path forward.  MedBuzz: In this episode of Oncology Unscripted, Dr John Marshall reflects on a trip to South Africa and what it revealed about survival, inequity, and the luxury of modern cancer care. Through exper...

MedBuzz: In this episode of Oncology Unscripted , John Marshall, MD, discusses a troubling week in health care news, including upheaval at the FDA, concerns about reduced federal support for medical education, and growing evidence that AI-generated fabricated references are appearing in published scientific literature. Main Topic: In this episode of Oncology Unscripted , Dr John Marshall previews...

MedBuzz: In this episode of Oncology Unscripted MedBuzz, Dr Marshall discusses evolving rectal cancer data and the growing role of genomic testing. He also reflects on US science policy and concerns about instability, and the need to modernize clinical trials while protecting independent oversight and patient data. Main Topic: In this episode of Oncology Unscripted, Dr Marshall discusses the growi...

MedBuzz: In this MedBuzz, Dr John Marshall discusses Steve Ubl’s departure from PhRMA and what it may signal for drug pricing, pharmaceutical policy, payer dynamics, and patient access.  Main Topic: In this episode of Oncology Unscripted, Dr John Marshall explores the growing role of AI in cancer care, from analyzing patient data and predicting treatment responses to supporting clinical trials, gu...

MedBuzz: After a trip to the Galapagos, Dr John Marshall reflects on evolution in nature, cancer, and medicine. From Darwin’s observations to the rise of AI and precision oncology, he explores how rapidly cancer adapts, how technology is reshaping care, and why the future of medicine must still preserve the human touch. Main Topic: In this episode of Oncology Unscripted, Dr John Marshall reflects...

MedBuzz: Watch now as Dr Marshall discusses the growing instability at the FDA, including job cuts, leadership turnover, and structural reorganization. Main Topic: This episode of Oncology Unscripted explores the projected $25 trillion global cost of cancer care, rising cancer incidence, and declining mortality, all set against political and funding uncertainty in frozen Washington, DC. Interview:...

Oncology Unscripted at ASCO GI: People, Pipelines, and Precision John Marshall, MD: Hello, everybody, from San Francisco, California. My name is Dr. John Marshall, and you are on—maybe unwisely— Oncology Unscripted. But thanks for joining me. I love this meeting, but let's first talk about the news of 2026. Top of the line is: we're out to get new countries. Now, I'm sort of running for mayor of H...

MedBuzz Tariffs, Taxes, and Trade-Offs: Can Raising Taxes in the UK Get You Cheaper Drugs in the US? John Marshall, MD: John Marshall for Oncology Unscripted . There's been all sorts of stuff going on out there in healthcare—in the business of healthcare—and a recent article that was just published in The New York Times told us something about the relationship between the National Health Service,...

MedBuzz: From Hormones to Heroines: Couric, Cancer, and the Case for Change John Marshall, MD Hello, everybody. John Marshall for Oncology Unscripted , coming to you from my now almost empty office. I've been in this office for, gosh, 20-plus years. It's the big office. You may or may not know I stepped down as the division chief here at Georgetown. We planned it—I wanted to do it a while ago. The...

MEDBUZZ [0:00:05] When the Sources of Trusted Information Change—Who Do We Believe? John Marshall, MD: Happy whatever day it is today when you're watching this. John Marshall for Oncology Unscripted . A little bit of a rainy day here in Washington, DC. It's been a little bit of a weird time here in Washington, DC—even weirder than it normally has been. Let's start with a little of the business of...

[00:00:05] Main Topic  ESMO, Efficiency, and Evidence: New Data, China’s Science Leap, and Leucovorin and Autism  John Marshall, MD : Hey everybody, John Marshall from Oncology Unscripted . There is so much going on right now that we're gonna need a full hour-long show, but we're not gonna do that to you. We still promise short bites here and there of the stuff that's going on, just to make sure y...

[00:00:05] MedBuzz: Back to Being ‘Just a Doctor’ John Marshall, MD : John Marshall for Oncology Unscripted , coming to you live from this big office. This is the biggest office because, you know, I've been the Chief of the Division here at Georgetown for 20 years. I didn't want the job when I was first offered it a long time ago. I ended up saying yes. Of course, that's a dramatic change in one's...

Why Are More Healthy Young Adults Getting GI Cancer? [00:05] John Marshall, MD : John Marshall for Oncology Unscripted . Big paper coming out of _JAMA_—it's actually a review article. Really, really smart people and friends up in Boston looked at this. We all see it: this emerging trend of younger and younger people getting all kinds of cancer. This particular paper wasn’t about all kinds of cance...

ACCESS THROUGH INNOVATION: THE POWER OF SMARTER CANCER CARE STRATEGIES [00:00:05] John Marshall, MD: John Marshall for Oncology Unscripted . Really no script at all, but we are post-ASCO here in Washington, DC, trying to take all of those major innovations that we all get so excited about—curves with big deltas that we saw in all sorts of different cancers, including the humblest of them all: GI c...

“Badge-up” with Dr Marshall at ASCO 2025 John Marshall, MD: John Marshall coming to you live Oncology Unscripted , not from my office back in Georgetown, but from beautiful downtown Chicago, Illinois at ASCO 2025. Look at this amazing place. 40,000 of our closest friends. To get in, you need to have one of these. So, I'm gonna go ahead and badge up. I got a fancy red collar thing here, boy, that m...

Badges, Booths, and Buses: Welcome to ASCO 2025 John Marshall, MD: John Marshall Oncology Unscripted. You know what this is? Yeah. You know what this is. This is my ASCO badge. It is that time of year again where I. I don't know, 40, 50, 60,000 of us and our closest friends all fly up to Chicago, stay in hotels that are overpriced, get bused around downtown Chicago, even on Saturday and Sunday. We...

No Evidence of Disease—No Need for the Knife? John Marshall, MD: John Marshall for Oncology Unscripted . Let's talk a little science and cancer medicine. I’m gonna come at you from a little bit of a different angle. Yep. A GI cancer angle, but a little bit different. We have long felt in order to cure GI cancers, we had to do surgery, that it was the only way to ultimately cure people. But we all...

We Funded the Cure—Now We're Pulling the Plug? John Marshall: Welcome to Washington DC. My name is John Marshall. This is Oncology Unscripted . There is a whole lot of stuff going on out there, seemingly unscripted, seemingly without much in the way of a sense of motivation, really a plan. It's just blow it up. Let's see what'll happen after the fact.  But let's stop for just a second and think ab...

Published, Performed, Passed Over—Because Science Still Has a Gender Problem [00:00:05] John Marshall, MD: John Marshall, Oncology Unscripted . It's unscripted because you can't make this stuff up. I don't know if your week or the last two has been anything like mine, but our country and our science and healthcare, and all of that stuff, is really undergoing an incredible number of changes so quic...

THE WEIGHT OF THE WHITE COAT: BATTLING BURNOUT How Do Middlemen Impact Our Practices? [00:00:00] John Marshall, MD: Welcome back everybody to Oncology Unscripted. It is August and if you're lucky like I am, August is vacation time for me. I am at this beautiful place somewhere in the south, somewhere near a golf course and an ocean; a little river flowing right over there, some egrets and an occas...

John Marshall, MD: Hey, everybody. John Marshall with Oncology Update. Welcome back. This is episode 5.  We now have a really cool function called ask a question. Click on that. Send us something. We hope to get back with you with an answer. Most of the time, you know, you see these things and it's all nailed down, and you know exactly what you're about to get. Not so much with this. We’re really...

[00:00:00] John Marshall, MD: Hey everybody, this is, believe it or not, episode four of Oncology Update , where we're really trying to get to, God should we say it, the truth in oncology. There's so much going on out there. It's a complex business. There's a lot of really cool science. There's a lot of progress going on. We're affecting a lot of people's lives, including our own.  So, let's jump...

Oncology Update: Introduction [00:00:00] John Marshall, MD: Welcome back to Oncology Update. My name is John Marshall here from Georgetown University, Washington, D. C., the land of freedom. I don't know what it is the land of anymore, but welcome back to Episode 3 of Oncology Update.  Our theme for this session is going to be, how do you stay up to date? How do your patients stay up to date with...

John Marshall, MD: Hey everybody, John Marshall for Oncology Update. Believe it or not, second episode. They let me do a second one. There's bad judgment on their part. ASCO Buzz [00:00:13] We're just back from ASCO, so you know how everybody's doing. You're still trying to pile out of your emails and figure out if you're actually going to get reimbursed for that dinner or not try for it. You neve...

[00:00:00] John Marshall, MD: Hey, everybody out there. This is John Marshall live from my office at Georgetown University. And this is oncology update for May 22, 2024. We're about one week out from ASCO. There's a lot going on, but first let's talk a little bit about what's going on out there in our business world in oncology today. Shifts & Shocks: Layoffs, Dose Reductions, and Drug Withdrawals...